Frequency and impact on renal transplant outcomes of urinary tract infections due to extended-spectrum beta-lactamase-producing and .

Publikation

Frequency and impact on renal transplant outcomes of urinary tract infections due to extended-spectrum beta-lactamase-producing and .

Wissenschaftlicher Artikel/Review - 15.02.2024

Brune Jakob E, Dickenmann Michael, Sidler Daniel, Walti Laura N, Golshayan Délaviz, Manuel Oriol, Haidar Fadi, Neofytos Dionysios, Schnyder Aurelia, Boggian Katia, Müller Thomas F, Schachtner Thomas, Khanna Nina, Schaub Stefan, Wehmeier Caroline, Swiss Transplant Cohort Study

Zitation

Brune J, Dickenmann M, Sidler D, Walti L, Golshayan D, Manuel O, Haidar F, Neofytos D, Schnyder A, Boggian K, Müller T, Schachtner T, Khanna N, Schaub S, Wehmeier C, Swiss Transplant Cohort Study. Frequency and impact on renal transplant outcomes of urinary tract infections due to extended-spectrum beta-lactamase-producing and . Front Med (Lausanne) 2024; 11:1329778.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

Front Med (Lausanne) 2024; 11

Veröffentlichungsdatum

15.02.2024

ISSN (Druck)

2296-858X

Seiten

1329778

Kurzbeschreibung/Zielsetzung

are often responsible for urinary tract infection (UTI) in kidney transplant recipients. Among these, or producing extended-spectrum beta-lactamase (ESBL) are emerging. However, there are only scarce data on frequency and impact of ESBL-UTI on transplant outcomes.